From package to protection: how do we close global coverage gaps to optimize the impact of vaccination?
Journal Title: Journal of Vaccines & Immunization - Year 2015, Vol 3, Issue 4
Abstract
The success of every vaccination program is dependent upon reaching and sustaining the target coverage rates. Vaccination programs are currently facing coverage gaps where target coverages are never reached and may also see erosion of coverage owing to, for example, loss of public confidence in vaccinations. The conference “From package to protection: how do we close global coverage gaps to optimize the impact of vaccination” gathered a multidisciplinary group of experts to explore the best options to address these gaps by challenging assumptions with evidence and focusing on impact. Within the broad challenge of increasing vaccine acceptance, there are many different circumstances depending on the disease, population demographics, culture and differences in health care systems. A basic requirement for addressing the coverage gap is to determine the relative contribution of each factor and to understand the underlying psychology of decision-making. Studies that aim at identifying and measuring drivers and barriers of vaccination, approaches to better understand the relative contribution of all possible determinants of vaccination uptake and evidence-based approaches to effective communication on vaccine risk and benefits were reviewed and discussed. The panel concluded that vaccination behaviour is a continuum phenomenon ranging from active demand to complete refusal of all vaccines and can vary through time, place and vaccine. Communication and interventional strategies should therefore be tailored by vaccine and population. Standardized and validated tools to measure the barriers and drivers of vaccine acceptance should be developed/tested and put together in a repository or "Matrix" of interventions to investigate the impact of intervention.
Authors and Affiliations
Thomson A, Watson M, Picot V, Louis J, Saadatian-Elahi M
Keywords
Related Articles
- EP ID EP566629
- DOI 10.14312/2053-1273.2015-4
- Views 87
- Downloads 0
Influenza and pneumococcal vaccination in hospitalized adults with pandemic (H1N1) 2009: Immunization practices and impact on clinical presentation and outcomes
The purpose of this study was to determine vaccination rates against influenza and pneumococcus in a large cohort of adults hospitalized with confirmed influenza A(H1N1) pdm09 infection, and to identify differences in cl...
Developing a vaccine for human rhinoviruses
Rhinoviruses (RV’s) are common human pathogens of the respiratory tract being the most frequent cause of mild diseases of the upper respiratory tract (common cold) but more importantly they are a major initiator of acute...
From package to protection: how do we close global coverage gaps to optimize the impact of vaccination?
The success of every vaccination program is dependent upon reaching and sustaining the target coverage rates. Vaccination programs are currently facing coverage gaps where target coverages are never reached and may also...
Silk-based microneedle transdermal immunization with EV71 vaccines elicits potent immune responses in mice
Hand, foot, and mouth disease (HFMD), caused by EV71 viral infection, has emerged as a serious public health concern in the Asia-Pacific region. The lack of effective treatment has led to a focus on controlling EV71 epid...
Events following BCG vaccination during neonatal period and factors that might affect potency and side effects
Introduction: In Sri Lanka, BCG vaccine is given during neonatal period. There are many myths regarding BCG vaccine and sequelae of vaccination are not clearly documented in medical literature. Objectives: Objectives of...